ISCC-PEG Pharmacogenomics Learning Series: Direct-to-Consumer Pharmacogenomic Testing
This online, self-paced, text-based module explores common nomenclature in pharmacogenomics (PGx). It was developed by the National Human Genome Research Institute (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG) and can be taken independently either free of charge or for continuing education credit depending upon the learner needs.
All healthcare professionals
Upon completion of this activity, participants should be able to:
- Differentiate between the delivery models for pharmacogenomic testing.
- Identify the benefits and limitations of direct-to-consumer (DTC) pharmacogenomic testing.
- Interpret DTC pharmacogenomic test results.
- Evaluate the clinical actionability of genetic variants detected by a DTC pharmacogenomic test using evidence-based resources.
- Determine when confirmatory clinical testing is needed when faced with DTC pharmacogenomic test results.
- Explain why confirmatory clinical pharmacogenomic test results may differ from direct-to-consumer pharmacogenomic test results for the same patient.
- Discuss issues related to documenting DTC pharmacogenomic test results in the electronic health record.
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series:
- Philip Empey, PharmD, PhD, FCCP (University of Pittsburgh School of Pharmacy)
- Andrew Monte, MD, PhD (University of Colorado)
- Trina Walker, DNP, APRN, FNP-C (Creighton University)
- Nguyen Park, MS, PA-C (National Human Genome Research Institute)
- Jeneva Gularte-Rinaldo, PhD, RN (Samuel Merritt University)
Spoorthy Reddy - University of Colorado
Additional Content Reviewers:
- Christina Aquilante, PharmD, Director of Pharmacogenomics for the Colorado Center for Personalized Medicine; Professor, Department of Pharmaceutical Sciences; University of Colorado
- Kathy Giacomini, PhD, Dean and Professor, School of Pharmacy; Co-Director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation; University of California, San Francisco
Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 1.00 AAPA Category I CME
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance
The content for this training is not hosted on this website, please access the training via the Test2learn website:
You should log in or register here only after you review the educational content for this course.
To complete the post-test and course evaluation to receive your credits and certificate:
- Choose Register/Complete Course to complete the module.
- First time Users: If you have never completed training on this website, please select register in the upper right hand corner of the webpage.
- Returning Users: If you have completed training on this website, please log in in the upper right hand corner of the webpage.